Novartis to buy pharmaceutical group AAA for US$3.9b
Zurich
NOVARTIS is buying French-based Advanced Accelerator Applications (AAA) for US$3.9 billion, giving the Swiss drugmaker a platform in radiopharmaceuticals and access to a new therapy for the kind of cancer that killed Steve Jobs.
The cash offer of US$41 per ordinary share and US$82 per American depositary share represents a 47 per cent premium to AAA's price before media reports on Sept 27 that Novartis was interested. The ADS closed on Friday at US$7…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Keppel DC Reit reports 13.7% lower Q1 DPU of S$0.02192 amid loss allowances
Gazelle Ventures makes cash offer for No Signboard shares at S$0.0021 apiece
Singapore shares open higher on Friday; STI up 0.2%
TSMC estimates losses of US$92.4 million due to Taiwan earthquake
Singapore loses ‘world’s best airport’ crown to Qatar
Higher gross rental income, lower expenses boost CICT’s Q1 NPI by 6.3%